Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Drop in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a significant drop in short interest during the month of October. As of October 30th, there was short interest totaling 115,580 shares, a drop of 66.3% from the October 15th total of 342,847 shares. Currently, 5.0% of the company’s shares are sold short. Based on an average trading volume of 766,639 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Read Our Latest Research Report on RKDA

Arcadia Biosciences Price Performance

RKDA opened at $0.22 on Friday. The company has a market capitalization of $535,020.00, a price-to-earnings ratio of -0.05 and a beta of 0.63. The business’s 50-day moving average price is $0.28 and its two-hundred day moving average price is $0.93. Arcadia Biosciences has a 1 year low of $0.11 and a 1 year high of $3.87.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its quarterly earnings results on Thursday, November 12th. The basic materials company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.46) by $0.75. Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%. The firm had revenue of $1.62 million during the quarter, compared to the consensus estimate of $2.40 million.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc. is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications. Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.

Further Reading

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.